TP53 and head and neck squamous cell carcinoma: The relationship between the tumor mutation burden (TMB), including TP53 mutations, and clinical relevance was analyzed using the expression data of 546 head and neck squamous cell carcinoma (HNSCC) patients from the Cancer Genome Atlas database (36).